Innovative Fundamentals

IMTH -  USA Stock  

USD 1.70  0.44  34.92%

Innovative Medtech fundamentals help investors to digest information that contributes to Innovative Medtech's financial success or failures. It also enables traders to predict the movement of Innovative OTC Stock. This fundamental analysis module provides a way for investors to measures Innovative Medtech's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Innovative Medtech otc stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Innovative Fundamentals 

 
Refresh

Innovative Current Valuation Analysis

Innovative Medtech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value 
 = 
Market Cap + Debt 
-  
Cash 
More About Current Valuation | All Equity Analysis

Current Innovative Medtech Current Valuation

    
  28.64 M  
Most of Innovative Medtech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Innovative Medtech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Compare to competition

In accordance with the recently published financial statements, Innovative Medtech has a Current Valuation of 28.64 M. This is 99.8% lower than that of the Healthcare sector and 99.69% lower than that of the Medical Instruments & Supplies industry. The current valuation for all United States stocks is 99.83% higher than that of the company.

Innovative Medtech Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Innovative Medtech's current stock value. Our valuation model uses many indicators to compare Innovative Medtech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Innovative Medtech competition to find correlations between indicators driving Innovative Medtech's intrinsic value. More Info.
Innovative Medtech is currently regarded as number one stock in shares owned by insiders category among related companies. It is rated third overall in z score category among related companies totaling about  0.08  of Z Score per Shares Owned by Insiders. The ratio of Shares Owned by Insiders to Z Score for Innovative Medtech is roughly  11.79 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Innovative Medtech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Innovative Medtech's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Innovative Medtech's earnings, one of the primary drivers of an investment's value.

Innovative Shares Owned by Insiders Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Innovative Medtech's direct or indirect competition against its Shares Owned by Insiders to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Innovative Medtech could also be used in its relative valuation, which is a method of valuing Innovative Medtech by comparing valuation metrics of similar companies.
Innovative Medtech is currently under evaluation in shares owned by insiders category among related companies.

Innovative Fundamentals

About Innovative Medtech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Innovative Medtech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innovative Medtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innovative Medtech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Innovative MedTech Inc., through its subsidiaries, provides health and wellness services in the United States. The company franchises and provides adult day care center services, including nursing care, salon services, meals, and other engaging and socialization activities. It operates 2 corporate and 27 franchise locations. The company was formerly known as Fresh Harvest Products, Inc. and changed its name to Innovative MedTech Inc. in March 2021. Innovative MedTech Inc. was incorporated in 2005 and is based in Blue Island, Illinois.

Innovative Medtech Investors Sentiment

The influence of Innovative Medtech's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Innovative. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Innovative Medtech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Innovative Medtech's short interest history, or implied volatility extrapolated from Innovative Medtech options trading.

Current Sentiment - IMTH

Innovative Medtech Investor Sentiment

Macroaxis portfolio users are indifferent in their judgment towards investing in Innovative Medtech. What is your judgment towards investing in Innovative Medtech? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Innovative Medtech using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Innovative Medtech Piotroski F Score and Innovative Medtech Altman Z Score analysis. Note that the Innovative Medtech information on this page should be used as a complementary analysis to other Innovative Medtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Innovative OTC Stock analysis

When running Innovative Medtech price analysis, check to measure Innovative Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovative Medtech is operating at the current time. Most of Innovative Medtech's value examination focuses on studying past and present price action to predict the probability of Innovative Medtech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Innovative Medtech's price. Additionally, you may evaluate how the addition of Innovative Medtech to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Is Innovative Medtech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innovative Medtech. If investors know Innovative will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innovative Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Innovative Medtech is measured differently than its book value, which is the value of Innovative that is recorded on the company's balance sheet. Investors also form their own opinion of Innovative Medtech's value that differs from its market value or its book value, called intrinsic value, which is Innovative Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovative Medtech's market value can be influenced by many factors that don't directly affect Innovative Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovative Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine Innovative Medtech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovative Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.